HENGOED-BASED pharmaceutical company Norgine has confirmed it is to shed 36 jobs. Chief operating officer Peter Martin said the move was in direct response to a drop in demand because of the downturn in the wider economy. “Norgine has been affected by the downturn in the global economy and the increasing use of generic copies of branded products,” he said. “This means the company has experienced a significant decrease in demand for some of products it manufactures. “As a consequence of this, Norgine is conducting a consultation on a proposal to make 36 of the current 400-strong workforce redundant.”
